An interventional study of Exercise in Focus Type 2 Diabetes Related Chronic Kidney Disease, sponsored by University of Minnesota. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2015-07-24.
Sponsored by University of Minnesota · Not applicable, Interventional, and Treatment
The general objective is to investigate the effect of a 12 week walking exercise program on vascular endothelial function, arterial stiffness/compliance, and vascular health biomarkers in men and women with pre-dialysis type 2 diabetic kidney disease (DKD).
3,840 studies on the registry are indexed under Kidney Diseases; 500 are open to participants now.
This study's enrollment of 122 is above the median of 70 across 2,640 interventional studies indexed under Kidney Diseases.
Browse Kidney Diseases studies →University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.
Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
Have diagnosed type 2 diabetic mellitus by one of the following criteria:
o Treated with diet, diet plus oral hypoglycemic agents (for at least one year), or insulin preceded by treatment with oral agents (for at least one year).
If treated with insulin, the onset of diabetes must have occurred after age of 40 and the body mass index must be >25kg/m2 at the time of diagnosis.
Diagnosed kidney attributed to diabetes by one of the following criteria:3
At least 2 of 3 samples should fall within the range of micro or macroalbuminuria.
Exclusion Criteria:
Patients are currently exercising
blended supervised-hombased exercise training 3-4 times/week for 12 weeks
Behavioral: Exercise
control group asked to continue usual activities
Blended supervised-home based walking program 3-4 times per week for at least 30 minutes.
endothelial function measured by brachial artery flow mediated vasodilation
Endothelium-mediated change in in vascular tone
Time frame: at week 0 and at week 12
arterial stiffness measured by pulse wave velocity
Time frame: at week 0 and at week 12
Circulating markers of vascular health
C-reactive protein, isoprostane F2, Asymmetric dimethylarginine
Time frame: at week 0 and at week 12
aerobic capacity
Peak oxygen consumption
Time frame: at week 0 and at week 12
blood pressure
Time frame: at week 0 and at week 12
24-hour albuminuria
assessed in 30 participants measured in milligram per gram creatinine
Time frame: at week 0 and at week 12
This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Minnesota